IP Library › Assignment 048675/0297
Patent Assignment
Reel/Frame 048675/0297

Assignee Change of Address

Recorded: 2019-03-22 Pages: 3
Assignor
PRINCIPIA BIOPHARMA INC.
Executed: 2019-02-07
Assignee
PRINCIPIA BIOPHARMA INC.
220 E. GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (42)
Tyrosine Kinase Inhibitors
Patent: 8,957,080 →
Application: 13/859,569 →
Publication: US 2014/0303161
Tyrosine Kinase Inhibitors
Patent: 8,673,925 →
Application: 13/929,004 →
Tyrosine Kinase Inhibitors
Patent: 8,759,358 →
Application: 13/929,179 →
Purinone Derivatives as Tyrosine Kinase Inhibitors
Application: 14/084,519 →
Publication: US 2014/0142099
Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors
Patent: 9,376,438 →
Application: 14/117,927 →
Publication: US 2014/0221398
Tyrosine Kinase Inhibitors
Patent: 8,962,831 →
Application: 14/117,933 →
Publication: US 2014/0094459
Tyrosine Kinase Inhibitors
Patent: 8,946,241 →
Application: 14/185,687 →
Publication: US 2014/0303190
Tyrosine Kinase Inhibitors
Patent: 9,090,621 →
Application: 14/255,842 →
Publication: US 2014/0309223
Tyrosine Kinase Inhibitors
Patent: 8,962,635 →
Application: 14/341,421 →
Publication: US 2014/0336382
SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS KINASE INHIBITORS
Patent: 9,266,895 →
Application: 14/374,788 →
Publication: US 2015/0094295
Formulations Containing Reversible Covalent Compounds
Application: 14/403,744 →
Publication: US 2016/0045503
Formulations Comprising Ibrutinib
Application: 14/403,927 →
Publication: US 2015/0140085
Treatment of Dry Eye
Patent: 9,572,811 →
Application: 14/418,484 →
Publication: US 2015/0182530
SUBSTITUTED PYRROLO[2,3-b]PYRAZINES AS JAK3 INHIBITORS
Patent: 9,676,778 →
Application: 14/443,705 →
Publication: US 2015/0291600
Pyrazolopyrimidine Compounds as Kinase Inhibitors
Patent: 8,940,744 →
Application: 14/464,602 →
Publication: US 2014/0364410
Tyrosine Kinase Inhibitors
Application: 14/590,851 →
Publication: US 2015/0353557
Tyrosine Kinase Inhibitors
Application: 14/741,311 →
Publication: US 2015/0353562
Purinone Derivatives as Tyrosine Kinase Inhibitors
Application: 14/997,248 →
Publication: US 2016/0257686
SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS KINASE INHIBITORS
Patent: 9,994,576 →
Application: 14/997,330 →
Publication: US 2016/0251358
Salts and Solid Form of a Btk Inhibitor
Application: 15/120,293 →
Publication: US 2017/0065591
Treatment of Pemphigus
Application: 15/537,294 →
Publication: US 2018/0050027
Site Specific Dosing of a Btk Inhibitor
Application: 15/539,094 →
Publication: US 2018/0015088
Compositions for Ileo-Jejunal Drug Delivery
Application: 15/539,100 →
Publication: US 2018/0193274
Tyrosine Kinase Inhibitors
Application: 15/738,051 →
Publication: US 2018/0305350
SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS KINASE INHIBITORS
Application: 15/978,041 →
Publication: US 2018/0327413
Salts and Solid Form of a Btk Inhibitor
Application: 16/116,425 →
Publication: US 2019/0076435
Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
Application: 16/312,258 →
Publication: US 2019/0231784
Tyrosine Kinase Inhibitors
Application: 61/486,944 →
Tyrosine Kinase Inhibitors
Application: 61/514,892 →
Tyrosine Kinase Inhibitors
Application: 61/556,336 →
Tyrosine Kinase Inhibitors
Application: 61/618,152 →
Salts and Solid Form of a Btk Inhibitor
Application: 61/943,262 →
Salts and Solid Form of a Btk Inhibitor
Application: 61/946,480 →
Treatment of Pemphigus
Application: 62/093,891 →
Salts and Solid Form of a Btk Inhibitor
Application: 62/096,468 →
Site Specific Administration of a Btk Inhibitor
Application: 62/096,809 →
Compositions for Ileo-Jejunal Drug Delivery
Application: 62/096,812 →
Tyrosine Kinase Inhibitors
Application: 62/170,547 →
Tyrosine Kinase Inhibitors
Application: 62/183,969 →
Tyrosine Kinase Inhibitors
Application: 62/271,689 →
Tyrosine Kinase Inhibitors
Application: 62/271,715 →
Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
Application: 62/356,345 →
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 20, 2013
From: GOLDSTEIN, DAVID MICHAEL; BRAMELD, KENNETH ALBERT
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 030655/0087 →
Assignment of Assignor's Interest Feb 3, 2014
From: GOLDSTEIN, DAVID MICHAEL; BRAMELD, KENNETH ALBERT
To: PRINCIPIA BIOPHARMA, INC.
Reel/Frame 032125/0014 →
Assignment of Assignor's Interest Aug 22, 2014
From: OWENS, TIM; VERNER, ERIK
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 033594/0216 →
Assignment of Assignor's Interest Nov 12, 2014
From: GOLDSTEIN, DAVID MICHAEL; BRAMELD, KENNETH ALBERT
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 034159/0622 →
Assignment of Assignor's Interest Apr 13, 2015
From: GOLDSTEIN, DAVID MICHAEL
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 035391/0655 →
Assignment of Assignor's Interest May 20, 2015
From: BABLER, MARTIN; GERRITSEN, MARY E
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 035676/0102 →
Assignment of Assignor's Interest Jul 29, 2015
From: GOLDSTEIN, DAVID MICHAEL; BERNER, BRET
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 036204/0150 →
Assignment of Assignor's Interest Sep 8, 2015
From: GOLDSTEIN, DAVID MICHAEL; BRAMELD, KENNETH ALBERT; OWENS, TIM
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 036513/0084 →
Assignment of Assignor's Interest Jan 15, 2016
From: OWENS, TIMOTHY D.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 037503/0532 →
Assignment of Assignor's Interest Aug 22, 2017
From: OWENS, TIM; VERNER, ERIK
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 043362/0101 →
Assignment of Assignor's Interest Dec 19, 2017
From: GOLDSTEIN, DAVID; OWENS, TIMOTHY D.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 044440/0602 →
Assignment of Assignor's Interest Mar 15, 2019
From: OWENS, TIMOTHY D.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 048616/0474 →
Assignment of Assignor's Interest Mar 15, 2019
From: GOLDSTEIN, DAVID MICHAEL; BRAMELD, KENNETH ALBERT
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 048616/0498 →
Assignment of Assignor's Interest Mar 15, 2019
From: GOLDSTEIN, DAVID MICHAEL; BRAMELD, KENNETH ALBERT
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 048616/0519 →
Assignee Change of Address Sep 16, 2025
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072881/0270 →